BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
See today's BioWorld Asia
Home
» Other news to note for Feb. 16, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Feb. 16, 2021
Feb. 16, 2021
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Aerami, Antibe, Apollomics, Aqualung, Atea, Azurrx, Biontech, Celltrion, China SXT, Edison Oncology, Eikonizo, Glaxosmithkline, Hangzhou Chance, Hengrui Medicine, Iterion, Jemincare, Jubilant Biosys, Lassen, Moderna, Nuance, Olix, Otsuka, Pfizer, PPD, Sandoz International, Sunshine, Tyg Oncology, Yingli.
BioWorld Asia
Briefs
Other news to note